SK13812001A3 - Deriváty diarylu, ich použitie na prípravu liečiva a farmaceutická kompozícia s ich obsahom - Google Patents
Deriváty diarylu, ich použitie na prípravu liečiva a farmaceutická kompozícia s ich obsahom Download PDFInfo
- Publication number
- SK13812001A3 SK13812001A3 SK1381-2001A SK13812001A SK13812001A3 SK 13812001 A3 SK13812001 A3 SK 13812001A3 SK 13812001 A SK13812001 A SK 13812001A SK 13812001 A3 SK13812001 A3 SK 13812001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- dimethylphenyl
- acid
- oxamic acid
- hydroxyphenoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28010599A | 1999-03-29 | 1999-03-29 | |
PCT/EP2000/002683 WO2000058279A1 (en) | 1999-03-29 | 2000-03-27 | Diaryl derivatives and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
SK13812001A3 true SK13812001A3 (sk) | 2002-04-04 |
Family
ID=23071698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1381-2001A SK13812001A3 (sk) | 1999-03-29 | 2000-03-27 | Deriváty diarylu, ich použitie na prípravu liečiva a farmaceutická kompozícia s ich obsahom |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1165502A1 (ru) |
JP (1) | JP2002540189A (ru) |
KR (1) | KR20010105394A (ru) |
CN (1) | CN1345309A (ru) |
AU (1) | AU4290800A (ru) |
BR (1) | BR0009431A (ru) |
CA (1) | CA2361016A1 (ru) |
CO (1) | CO5160290A1 (ru) |
CZ (1) | CZ20013449A3 (ru) |
HK (1) | HK1042692A1 (ru) |
HU (1) | HUP0200588A2 (ru) |
IL (1) | IL144637A0 (ru) |
MX (1) | MXPA01009843A (ru) |
NO (1) | NO20014702D0 (ru) |
NZ (1) | NZ514062A (ru) |
PE (1) | PE20001587A1 (ru) |
PL (1) | PL349355A1 (ru) |
RU (1) | RU2001126579A (ru) |
SK (1) | SK13812001A3 (ru) |
TR (1) | TR200102225T2 (ru) |
WO (1) | WO2000058279A1 (ru) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE200100464A (et) | 1999-03-01 | 2002-12-16 | Pfizer Products Inc. | Oksaamhapped ja derivaadid kui türoidretseptori ligandid |
US6790978B2 (en) | 1999-03-29 | 2004-09-14 | Novartis Ag | Thyromimetic organic compounds |
AU2001230929B2 (en) | 2000-02-17 | 2004-09-23 | Bristol-Myers Squibb Co. | Aniline-derived ligands for the thyroid receptor |
US6664291B2 (en) | 2000-03-31 | 2003-12-16 | Pfizer, Inc. | Malonamic acids and derivatives thereof as thyroid receptor ligands |
BR0109625A (pt) * | 2000-03-31 | 2003-04-22 | Pfizer Prod Inc | cidos malonñmicos e seus derivados como ligandos do receptor da tireóide |
WO2001085670A1 (fr) * | 2000-05-12 | 2001-11-15 | Kissei Pharmaceutical Co., Ltd. | Derives d'acide malonanilique, compositions medicinales les contenant et leur utilisation |
US6395784B1 (en) | 2000-06-07 | 2002-05-28 | Bristol-Myers Squibb Company | Benzamide ligands for the thyroid receptor |
DE10038007A1 (de) * | 2000-08-04 | 2002-02-14 | Bayer Ag | Neue Amino-und Amido-Diphenylether für Arzneimittel |
DE10046029A1 (de) | 2000-09-18 | 2002-03-28 | Bayer Ag | Indazole |
AU2002223626A1 (en) * | 2000-10-20 | 2002-04-29 | Novartis Ag | Combinations of a thyromimetic compound and a statin |
EP1347959A1 (de) * | 2000-12-27 | 2003-10-01 | Bayer Aktiengesellschaft | Indol-derivate |
US6777442B2 (en) | 2001-03-12 | 2004-08-17 | Bayer Aktiengesellschaft | Diphenyl derivatives |
DE10122443A1 (de) * | 2001-05-09 | 2002-11-14 | Bayer Ag | Amido-Diphenyl-Derivate |
US6777443B2 (en) | 2001-05-15 | 2004-08-17 | Novartis Ag | Dipeptide derivatives |
DK1262177T3 (da) * | 2001-05-31 | 2006-11-20 | Pfizer Prod Inc | Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner |
DE10131462A1 (de) * | 2001-06-29 | 2003-01-09 | Bayer Ag | Phenol-Derivate |
ATE313325T1 (de) | 2001-09-26 | 2006-01-15 | Pfizer Prod Inc | Indolcaroboxylsäure als thyroidrezeptor-liganden |
US6818766B2 (en) | 2002-10-02 | 2004-11-16 | Synthon Bv | Process for making bicalutamide and intermediates thereof |
AU2006249350B2 (en) | 2003-11-19 | 2012-02-16 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
US7829552B2 (en) * | 2003-11-19 | 2010-11-09 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyromimetics |
WO2005105712A1 (en) * | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Sulfonamide derivatives |
WO2006014012A2 (en) | 2004-08-06 | 2006-02-09 | Otsuka Pharmaceutical Co., Ltd. | Aromatic compounds |
US8236826B2 (en) | 2005-12-05 | 2012-08-07 | Otsuka Pharmaceutical Co., Ltd. | Diarylether derivatives as antitumor agents |
UA95978C2 (ru) | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
WO2009133834A1 (ja) * | 2008-04-28 | 2009-11-05 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有するケトアミド誘導体 |
TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
CN104193699B (zh) * | 2014-08-14 | 2016-05-25 | 嘉兴特科罗生物科技有限公司 | 一种小分子化合物及其合成方法和应用 |
CN110198719A (zh) | 2016-11-21 | 2019-09-03 | 维京治疗公司 | 治疗糖原贮积病的方法 |
BR112019025659A2 (pt) | 2017-06-05 | 2020-08-25 | Viking Therapeutics, Inc. | composições para o tratamento de fibrose |
KR20200138283A (ko) | 2018-03-22 | 2020-12-09 | 바이킹 테라퓨틱스 인코포레이티드 | 결정질 형태, 및 결정질 형태의 화합물을 제조하는 방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0580550T3 (da) * | 1992-07-21 | 1998-02-02 | Ciba Geigy Ag | Oxamidsyrederivater som hypercholesterolæmiske midler |
-
2000
- 2000-03-22 CO CO00020338A patent/CO5160290A1/es unknown
- 2000-03-27 PE PE2000000260A patent/PE20001587A1/es not_active Application Discontinuation
- 2000-03-27 HU HU0200588A patent/HUP0200588A2/hu unknown
- 2000-03-27 WO PCT/EP2000/002683 patent/WO2000058279A1/en not_active Application Discontinuation
- 2000-03-27 BR BR0009431-5A patent/BR0009431A/pt not_active Application Discontinuation
- 2000-03-27 IL IL14463700A patent/IL144637A0/xx unknown
- 2000-03-27 PL PL00349355A patent/PL349355A1/xx not_active Application Discontinuation
- 2000-03-27 NZ NZ514062A patent/NZ514062A/xx not_active Application Discontinuation
- 2000-03-27 CA CA002361016A patent/CA2361016A1/en not_active Abandoned
- 2000-03-27 CN CN00805693A patent/CN1345309A/zh active Pending
- 2000-03-27 CZ CZ20013449A patent/CZ20013449A3/cs unknown
- 2000-03-27 EP EP00922557A patent/EP1165502A1/en not_active Withdrawn
- 2000-03-27 RU RU2001126579/04A patent/RU2001126579A/ru unknown
- 2000-03-27 SK SK1381-2001A patent/SK13812001A3/sk unknown
- 2000-03-27 MX MXPA01009843A patent/MXPA01009843A/es unknown
- 2000-03-27 KR KR1020017012250A patent/KR20010105394A/ko not_active Application Discontinuation
- 2000-03-27 TR TR2001/02225T patent/TR200102225T2/xx unknown
- 2000-03-27 JP JP2000607982A patent/JP2002540189A/ja active Pending
- 2000-03-27 AU AU42908/00A patent/AU4290800A/en not_active Abandoned
-
2001
- 2001-09-27 NO NO20014702A patent/NO20014702D0/no unknown
-
2002
- 2002-06-18 HK HK02104536.1A patent/HK1042692A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CO5160290A1 (es) | 2002-05-30 |
CZ20013449A3 (cs) | 2001-12-12 |
WO2000058279A1 (en) | 2000-10-05 |
JP2002540189A (ja) | 2002-11-26 |
NZ514062A (en) | 2001-09-28 |
IL144637A0 (en) | 2002-05-23 |
HUP0200588A2 (hu) | 2002-07-29 |
PL349355A1 (en) | 2002-07-15 |
NO20014702L (no) | 2001-09-27 |
PE20001587A1 (es) | 2001-01-31 |
CN1345309A (zh) | 2002-04-17 |
CA2361016A1 (en) | 2000-10-05 |
AU4290800A (en) | 2000-10-16 |
TR200102225T2 (tr) | 2002-01-21 |
HK1042692A1 (zh) | 2002-08-23 |
MXPA01009843A (es) | 2002-05-06 |
EP1165502A1 (en) | 2002-01-02 |
KR20010105394A (ko) | 2001-11-28 |
BR0009431A (pt) | 2002-01-08 |
NO20014702D0 (no) | 2001-09-27 |
RU2001126579A (ru) | 2004-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK13812001A3 (sk) | Deriváty diarylu, ich použitie na prípravu liečiva a farmaceutická kompozícia s ich obsahom | |
JP4253126B2 (ja) | Ppar−ガンマ調節剤 | |
US6316503B1 (en) | LXR modulators | |
DE60012700T2 (de) | Oxamsäure und deren derivate als liganden der thyroid-rezeptoren | |
US7511043B2 (en) | FXR modulators | |
EA011087B1 (ru) | Соединения и фармацевтические композиции для лечения воспалительных заболеваний | |
KR20070047319A (ko) | 호흡기 질환 치료용 비페닐옥시아세트산 유도체 | |
BRPI0712301A2 (pt) | composto, composição farmacêutica, método de antagonização de um receptor dp-2, e, uso de um composto | |
SK288236B6 (sk) | Chinolinylfenylsulfónamidová zlúčenina, jej použitie ako liečivo a farmaceutické prípravky obsahujúce túto zlúčeninu | |
CZ279630B6 (cs) | Amidinofenoxyalkoxybenzamidy, způsob jejich výrob y a jejich použití | |
SK281184B6 (sk) | Substituovaný sulfónamid, farmaceutická kompozícia na jeho báze a spôsob jeho prípravy | |
US6599942B1 (en) | Thyromimetic organic compounds | |
US6790978B2 (en) | Thyromimetic organic compounds | |
CS271469B2 (en) | Method of phenoxyalkylcarboxyl acid's derivatives production | |
JP7508422B2 (ja) | ピロリジン化合物 | |
KR19990063800A (ko) | 구아니디노 프로테아제 억제제 | |
JPH03255080A (ja) | ベンゼン化合物 | |
EP0430459B1 (en) | Tetrahydronaphthalene derivatives and preparation thereof | |
US7208526B2 (en) | Styrylsulfonamides | |
JPH07215929A (ja) | ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
JP7478251B2 (ja) | イオンチャネルアンタゴニスト/遮断剤およびその用途 | |
JP2002521437A (ja) | マクロファージ・スカベンジャー受容体アンタゴニスト | |
JP4431796B2 (ja) | 新規な抗マラリア剤 |